What happened, in summary

Fleur Profinet was 48 when she spoke about living with metastatic breast cancer and the way it changed family life. She first had breast cancer in 2013, then a recurrence beginning in 2020. Formal biomarker results, specific metastatic sites, surgery details, radiation details, and drug names were not shared. It does clearly report ongoing metastatic breast cancer and treatment by category: chemotherapy, targeted therapy, and hormone therapy. Fleur explained that these treatments brought fatigue, some pain, and mood changes. Her family sometimes tried to protect her too much, while at other times they forgot how much the disease and treatment still affected her. She emphasized that she wanted to remain a woman, a mother, a wife, and a patient—not only a patient. That balance mattered with her husband, teenage children, and wider support network. She also described the importance of speaking honestly with other women living with metastatic breast cancer, because they could share fears, information, hope, and everyday family frustrations. As of May 2022, Fleur said her oncologist considered her illness chronic and that, with chemotherapy, targeted therapy, and hormone therapy, her metastases were “sleeping.” That supports a responding-well status, not a cancer-free outcome overall.